Differential Binding of poly(ADP-ribose) polymerase-1 and JunD/Fra2 accounts for RANKL-induced Tcirg1 gene expression during osteoclastogenesis

Journal of Bone and Mineral Research

Volumn 22, Issue 7, 2007, Pages 975-983

  Beranger, Guillaume E ^a   Momier, David ^a   Guigonis, Jean Marie ^a   Samson, Michel ^b   Carle, Georges F ^a,c   Scimeca, Jean Claude ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

Activator protein 1 dimer; Fos related antigen 2; JunD proto oncogene; Osteoclast; Poly(ADP ribose) polymerase 1; RANKL; Tcirg1 promoter

Indexed keywords

ADENOSINE TRIPHOSPHATASE; DIMER; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG; VACUOLAR ADENOSINE TRIPHOSPHATASE A3; ATP6AP1 PROTEIN, MOUSE; CROSS LINKING REAGENT; HYBRID PROTEIN; MESSENGER RNA; PROTEIN C JUN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL LINE; COMPLEX FORMATION; DISSOCIATION; ENZYME BINDING; ENZYME INHIBITION; ENZYME RELEASE; ENZYME SUBUNIT; GEL MOBILITY SHIFT ASSAY; GENE; GENE DELETION; GENE INDUCTION; OSTEOCLAST; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ASSAY; SEQUENCE ANALYSIS; TCIRG1 GENE; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CYTOLOGY; DIMERIZATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; RADIATION EXPOSURE; ULTRAVIOLET RADIATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; CROSS-LINKING REAGENTS; DIMERIZATION; FOS-RELATED ANTIGEN-2; GENE EXPRESSION REGULATION; MICE; MICE, INBRED C57BL; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; OSTEOCLASTS; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; RANK LIGAND; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; ULTRAVIOLET RAYS; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 34548569303     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.070406     Document Type: Article

References (34)

1. 1 Francis MJ, Lees RL, Trujillo E, Martin‐Vasallo P, Heersche JN, Mobasheri A 2002 ATPase pumps in osteoclasts and osteoblasts. Int J Biochem Cell Biol 34: 459–476.
2. 2 Mattsson JP, Li X, Peng SB, Nilsson F, Andersen P, Lundberg LG, Stone DK, Keeling DJ 2000 Properties of three isoforms of the 116‐kDa subunit of vacuolar H+‐ATPase from a single vertebrate species. Cloning, gene expression and protein characterization of functionally distinct isoforms in Gallus gallus. Eur J Biochem 267: 4115–4126.
3. 3 Nishi T, Forgac M 2000 Molecular cloning and expression of three isoforms of the 100‐kDa a subunit of the mouse vacuolar proton‐translocating ATPase. J Biol Chem 275: 6824–6830.
4. 4 Oka T, Murata Y, Namba M, Yoshimizu T, Toyomura T, Yamamoto A, Sun‐Wada GH, Hamasaki N, Wada Y, Futai M 2001 a4, a unique kidney‐specific isoform of mouse vacuolar H+‐ATPase subunit a. J Biol Chem 276: 40050–40054.
5. 5 Toyomura T, Oka T, Yamaguchi C, Wada Y, Futai M 2000 Three subunit a isoforms of mouse vacuolar H(+)‐ATPase. Preferential expression of the a3 isoform during osteoclast differentiation. J Biol Chem 275: 8760–8765.
6. 6 Manolson MF, Yu H, Chen W, Yao Y, Li K, Lees RL, Heersche JN 2003 The a3 isoform of the 100‐kDa V‐ATPase subunit is highly but differentially expressed in large (> or = 10 nuclei) and small (< or = nuclei) osteoclasts. J Biol Chem 278: 49271–49278.
7. 7 Li YP, Chen W, Liang Y, Li E, Stashenko P 1999 Atp6i‐deficient mice exhibit severe osteopetrosis due to loss of osteoclast‐mediated extracellular acidification. Nat Genet 23: 447–451.
8. 8 Scimeca JC, Franchi A, Trojani C, Parrinello H, Grosgeorge J, Robert C, Jaillon O, Poirier C, Gaudray P, Carle GF 2000 The gene encoding the mouse homologue of the human osteoclast‐specific 116‐kDa V‐ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26: 207–213.
9. 9 Scimeca JC, Quincey D, Parrinello H, Romatet D, Grosgeorge J, Gaudray P, Philip N, Fischer A, Carle GF 2003 Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis. Hum Mutat 21: 151–157.
10. 10 Beranger GE, Momier D, Rochet N, Quincey D, Guigonis JM, Samson M, Carle GF, Scimeca JC 2006 RANKL treatment releases the negative regulation of the poly(adp‐ribose) polymerase‐1 on Tcirg1 gene expression during osteoclastogenesis. J Bone Miner Res 21: 1757–1769.
11. 11 Wagner EF, Eferl R 2005 Fos/AP‐1 proteins in bone and the immune system. Immunol Rev 208: 126–140.
12. 12 Behrens A, Haigh J, Mechta‐Grigoriou F, Nagy A, Yaniv M, Wagner EF 2003 Impaired intervertebral disc formation in the absence of Jun. Development 130: 103–109.
13. 13 Wang ZQ, Ovitt C, Grigoriadis AE, Mohle‐Steinlein U, Ruther U, Wagner EF 1992 Bone and haematopoietic defects in mice lacking c‐fos. Nature 360: 741–745.
14. 14 David JP, Rincon M, Neff L, Horne WC, Baron R 2001 Carbonic anhydrase II is an AP‐1 target gene in osteoclasts. J Cell Physiol 188: 89–97.
15. 15 Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, Wang KZ, Bachler MA, Amano H, Aburatani H, Ishikawa H, Wagner EF 2004 Nuclear factor of activated T‐cells (NFAT) rescues osteoclastogenesis in precursors lacking c‐Fos. J Biol Chem 279: 26475–26480.
16. 16 Wagner EF 2002 Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis 61 (Suppl 2): ii40–ii42.
17. 17 Yang X, Karsenty G 2002 Transcription factors in bone: Developmental and pathological aspects. Trends Mol Med 8: 340–345.
18. 18 Sobacchi C, Vezzoni P, Reid DM, McGuigan FE, Frattini A, Mirolo M, Albhaga OM, Musio A, Villa A, Ralston SH 2004 Association between a polymorphism affecting an AP1 binding site in the promoter of the TCIRG1 gene and bone mass in women. Calcif Tissue Int 74: 35–41.
19. 19 Lam J, Nelson CA, Ross FP, Teitelbaum SL, Fremont DH 2001 Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor‐ligand specificity. J Clin Invest 108: 971–979.
20. 20 Deng W, Stashenko P, Chen W, Liang Y, Shimizu K, Li YP 2001 Characterization of mouse Atp6i gene, the gene promoter, and the gene expression. J Bone Miner Res 16: 1136–1146.
21. 21 Adereth Y, Champion KJ, Hsu T, Dammai V 2005 Site‐directed mutagenesis using Pfu DNA polymerase and T4 DNA ligase. Biotechniques 38: 864, 866, 868.
22. 22 Liu Y, Shi Z, Silveira A, Liu J, Sawadogo M, Yang H, Feng X 2003 Involvement of upstream stimulatory factors 1 and 2 in RANKL‐induced transcription of tartrate‐resistant acid phosphatase gene during osteoclast differentiation. J Biol Chem 278: 20603–20611.
23. 23 Lallemand D, Spyrou G, Yaniv M, Pfarr CM 1997 Variations in Jun and Fos protein expression and AP‐1 activity in cycling, resting and stimulated fibroblasts. Oncogene 14: 819–830.
24. 24 Rezzonico R, Loubat A, Lallemand D, Pfarr CM, Far DF, Proudfoot A, Rossi B, Ponzio G 1995 Cyclic AMP stimulates a JunD/Fra‐2 AP‐1 complex and inhibits the proliferation of interleukin‐6‐dependent cell lines. Oncogene 11: 1069–1078.
25. 25 Yu Z, Kuncewicz T, Dubinsky WP, Kone BC 2006 Nitric oxide‐dependent negative feedback of PARP‐1 trans‐activation of the inducible nitric‐oxide synthase gene. J Biol Chem 281: 9101–9109.
26. 26 Kawaida R, Ohtsuka T, Okutsu J, Takahashi T, Kadono Y, Oda H, Hikita A, Nakamura K, Tanaka S, Furukawa H 2003 Jun dimerization protein 2 (JDP2), a member of the AP‐1 family of transcription factor, mediates osteoclast differentiation induced by RANKL. J Exp Med 197: 1029–1035.
27. 27 Heinrich R, Livne E, Ben‐Izhak O, Aronheim A 2004 The c‐Jun dimerization protein 2 inhibits cell transformation and acts as a tumor suppressor gene. J Biol Chem 279: 5708–5715.
28. 28 Wisdom R, Johnson RS, Moore C 1999 c‐Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J 18: 188–197.
29. 29 Marks SC Jr, Seifert MF 1985 The lifespan of osteoclasts: Experimental studies using the giant granule cytoplasmic marker characteristic of beige mice. Bone 6: 451–455.
30. 30 Roodman GD 2006 Regulation of osteoclast differentiation. Ann N Y Acad Sci 1068: 100–109.
31. 31 Andreone TL, O'Connor M, Denenberg A, Hake PW, Zingarelli B 2003 Poly(ADP‐ribose) polymerase‐1 regulates activation of activator protein‐1 in murine fibroblasts. J Immunol 170: 2113–2120.
32. 32 Dunn C, Wiltshire C, MacLaren A, Gillespie DA 2002 Molecular mechanism and biological functions of c‐Jun N‐terminal kinase signalling via the c‐Jun transcription factor. Cell Signal 14: 585–593.
33. 33 Katz S, Heinrich R, Aronheim A 2001 The AP‐1 repressor, JDP2, is a bona fide substrate for the c‐Jun N‐terminal kinase. FEBS Lett 506: 196–200.
34. 34 Takahashi N, Udagawa N, Suda T 1999 A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function. Biochem Biophys Res Commun 256: 449–455.